Skip to main content

Articles

Page 152 of 154

  1. Osteoarthritis is complex in genetics, pathogenesis, monitoring and treatment. Current treatment of osteoarthritis does not influence progression. Much could be gained by more effective 'low-tech-low-cost' tre...

    Authors: L Stefan Lohmander
    Citation: Arthritis Research & Therapy 2000 2:95
  2. Serum and synovial tissue expression of the matrix metalloproteinase (MMP)-2 and -9 and their molecular regulators, MMP-14 and TIMP-2 was examined in 28 patients with inflammatory early synovitis and 4 healthy...

    Authors: Raphaela Goldbach-Mansky, Jennifer M Lee, Joseph M Hoxworth, David Smith II, Paul Duray, H Ralph Schumacher Jr, Cheryl H Yarboro, John Klippel, David Kleiner and Hani S El-Gabalawy
    Citation: Arthritis Research & Therapy 2000 2:145
  3. Autoantibodies present in the serum of patients with a variety of inflammatory diseases have proven useful as diagnostic markers and as probes with which to elucidate biochemical and signaling pathways. The me...

    Authors: Paul J Utz,, Timothy J Gensler and Paul Anderson
    Citation: Arthritis Research & Therapy 2000 2:101
  4. A chance observation has led to the development of a new murine model for inflammatory arthritis. Arthritis is induced, and transferred, by T-cell-dependent antibodies to glucose-6-phosphate isomerase. This en...

    Authors: Hugh McDevitt
    Citation: Arthritis Research & Therapy 2000 2:85
  5. CD8+ T cells dominate the lymphocyte population insynovial fluid in chronic inflammatory arthritis. It is known that theseCD8+ T cells are often clonally or oligoclonally expanded, but theirspecificity and their ...

    Authors: Linda C Tan, Alastair G Mowat, Chrysoula Fazou, Tim Rostron, Helen Roskell, P Rod Dunbar, Claire Tournay, François Romagné, Marie-Alix Peyrat, Elisabeth Houssaint, Marc Bonneville, Alan B Rickinson, Andrew J McMichael and Margaret FC Callan
    Citation: Arthritis Research & Therapy 2000 2:154
  6. Cytokines play a critical role in the normal development and function of the immune system. On the other hand, many rheumatologic diseases are characterized by poorly controlled responses to or dysregulated pr...

    Authors: Robert A Ortmann, Tammy Cheng, Roberta Visconti, David M Frucht and John J O'Shea
    Citation: Arthritis Research & Therapy 1999 2:16
  7. IFN-γ was measured in supernatants after in vitro stimulation of peripheral blood mononuclear cells with collagen type II (CII), purified protein derivative or influenza virus. IFN-γ production in response to CII...

    Authors: Louise Berg, Johan Rönnelid, Carani B Sanjeevi, Jon Lampa and Lars Klareskog
    Citation: Arthritis Research & Therapy 1999 2(Suppl 1):75

    This article is part of a Supplement: Volume 2 Supplement 1

  8. In the present study, we searched for mutant PTEN transcripts in aggressive rheumatoid arthritis synovial fibroblasts (RA-SF) and studied the expression of PTEN in RA. By automated sequencing, no evidence for the...

    Authors: Thomas Pap, Juliane K Franz, Klaus M Hummel, Elvira Jeisy, Renate Gay and Steffen Gay
    Citation: Arthritis Research & Therapy 1999 2:59
  9. The present study was designed to analyze the level of B-cell clonal diversity in patients with rheumatoid arthritis by using HCDR3 (third complementarity determining region of the rearranged heavy chain varia...

    Authors: Kenji Itoh, Varsha Patki, Richard A Furie, Elliot K Chartash, Rita I Jain, Lewis Lane, Stanley E Asnis and Nicholas Chiorazzi
    Citation: Arthritis Research & Therapy 1999 2(Suppl 1):50

    This article is part of a Supplement: Volume 2 Supplement 1

  10. Case reports suggest that solvents are associated with various connective tissue diseases (systemic sclerosis, scleroderma, undifferentiated connective tissue disease, systemic lupus erythematosis, and rheumat...

    Authors: David H Garabrant and Constantine Dumas
    Citation: Arthritis Research & Therapy 1999 2:5

Annual Journal Metrics

  • 2022 Citation Impact
    4.9 - 2-year Impact Factor
    5.7 - 5-year Impact Factor
    1.501 - SNIP (Source Normalized Impact per Paper)
    1.592 - SJR (SCImago Journal Rank)

    2023 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    111 days submission to accept (Median)

    2023 Usage 
    3,331,819 downloads
    1,885 Altmetric mentions